Is non-invasive brain stimulation the low-hanging fruit?

Tom A. Graaf*, Shanice E.W. Janssens, Alexander T. Sack

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapterAcademic

Abstract

Mental health is a growing concern, with increases in diagnosed psychopathologies and associated costs. Traditionally, psychopathology has been treated with psychotherapy, drug therapy, or combinations of both. But recent years have seen the development of new approaches to directly target the biological basis for mental illness. For a range of disorders, neuromodulation using non-invasive brain stimulation (NIBS) constitutes a promising avenue to direct, comfortable, and focused CNS-targeted treatment (central nervous system). At the same time, neuromodulation using direct brain stimulation is sometimes touted as a tool with almost unlimited future and range of applications. We here discuss to what extent NIBS can indeed contribute to brain-based medicine, particularly clinical treatment. Is NIBS a passing trend? Or is NIBS the low-hanging fruit?
Original languageEnglish
Title of host publicationModern CNS Drug Discovery: Reinventing the Treatment of Psychiatric and Neurological Disorders
PublisherSpringer International Publishing
Pages115-128
Number of pages14
ISBN (Electronic)9783030623517
ISBN (Print)9783030623500
DOIs
Publication statusPublished - 17 Jun 2021

Keywords

  • Depression
  • Efficacy
  • Non-invasive brain stimulation (NIBS)
  • Repetitive transcranial magnetic stimulation (rTMS)
  • Treatment

Cite this